News about "Janssen Biotech"

U.S. Food and Drug Administration Approves Tec-Dara Combination Therapy for Relapsed Multiple Myeloma

U.S. Food and Drug Administration Approves Tec-Dara Combination Therapy for Relapsed Multiple Myeloma

U.S. Food and Drug Administration grants rapid approval to Tec-Dara, a combination of teclistamab and daratumumab hyaluronidase-fihj, for adults with relapsed or refractory multiple myeloma after at least one prior therapy.

Janssen Biotech | 07/03/2026 | By News Bureau

Ailux Biologics Forges License Deal with Janssen Biotech on Biologics AI Platform

Ailux Biologics Forges License Deal with Janssen Biotech on Biologics AI Platform

Under the agreement, Ailux Biologics grants Janssen and its affiliates a non-exclusive license to leverage its XtalFold platform for the discovery and engineering of biologics.

Janssen Biotech | 14/10/2024 | By Aishwarya 274


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members